Amgen
Since July 1, 2005 Professor Dirk Jäger has been heading the Department of Medical Oncology at the NCT Heidelberg and he is responsible for the entire clinical area at the NCT Heidelberg.
All oncological units at the University Hospital are integrated into the interdisciplinary outpatients' structure at the NCT Heidelberg. An important focus is translation of innovative therapeutic approaches into early clinical trials. The strategies that use the human immune system for the treatment of tumors play an important part.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Amgen
273 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.